AstraZeneca to build new Virginia plant as it re-hashes other U.S. investment plans


AstraZeneca, the U.K.-Swedish pharmaceutical giant, on Tuesday announced a plan to invest some $50 billion in the U.S. in a move hailed by the Trump administration — though much of what it is announcing it’s already announced before.

You May Also Like

German regulator criticises Deutsche Bank financial report

Standard Digital Weekend Print + Standard Digital Complete digital access to quality…

Airbus and Thales explore space tie-up

Airbus and Thales have held exploratory talks about merging some of their…

This neglected issue is a workplace productivity and talent retention threat that demands C-suite attention

Eldercare benefits aren’t just a nice perk. They’re essential to solving this…

Trump’s playbook may be tossed, but higher tariffs are here to stay — one way or another

Is Trump’s trade strategy in limbo? Yes, but ‘Tariff Man’ has options.